Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Common Stock | Options Exercise | $2.3M | +14.1K | +31.91% | $163.63 | 58.1K | Feb 21, 2024 | Direct | |
transaction | LH | Common Stock | Sale | -$3.96M | -18.4K | -31.63% | $215.37 | 39.7K | Feb 21, 2024 | Direct | F1 |
transaction | LH | Common Stock | Sale | -$1.71M | -7.91K | -19.91% | $215.68 | 31.8K | Feb 21, 2024 | Direct | F2 |
transaction | LH | Common Stock | Sale | -$1.45M | -6.67K | -20.95% | $217.52 | 25.1K | Feb 21, 2024 | Direct | F3 |
transaction | LH | Common Stock | Sale | -$339K | -1.55K | -6.18% | $217.98 | 23.6K | Feb 21, 2024 | Direct | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Non-qualified Stock Options | Options Exercise | $0 | -14.1K | -100% | $0.00* | 0 | Feb 21, 2024 | Common Stock | 14.1K | $163.63 | Direct | F5, F6, F7 |
Id | Content |
---|---|
F1 | The price of $215.3661 per share represents a weighted average of sales prices ranging from $214.80 to $215.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
F2 | The price of $215.6759 per share represents a weighted average of sales prices ranging from $215.80 to $216.66 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
F3 | The price of $217.5205 per share represents a weighted average of sales prices ranging from $216.87 to $217.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
F4 | The price of $217.9842 per share represents a weighted average of sales prices ranging from $217.89 to $218.075 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
F5 | Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. |
F6 | Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. |
F7 | The option vested in three equal annual installments beginning on the date reflected in this column. |